Manchester University NHS Foundation Trust: Phase 4 study completed, 657 enrolled (Liver Cirrhosis, Hepatocellular Carcinoma)
Manchester University NHS Foundation Trust: Phase 4 study completed, 657 enrolled (Liver Cirrhosis, Hepatocellular Carcinoma). Its enrollment of 657 is top-decile (92nd percentile of 8,879 records). Dated 27 days ago, it is in the active follow-up window. Score 40/100. As of 2026-11-04, from ClinicalTrials.gov (U.S. National Library of Medicine) API v2.
Data as of · Compiled by Zalwin from ClinicalTrials.gov (U.S. National Library of Medicine) API v2
enrollment: 657 · 92th percentile of 8,879 ClinicalTrialStartPulse records · 8.2x the median
Free preview: all 15 published fields of this record are shown below. Locked: 499 related ClinicalTrialStartPulse records and the 7-column CSV export.
| Field | Value |
|---|---|
| Sponsor | Manchester University NHS Foundation Trust |
| Sponsor type | Non-US government |
| Study | Real-world Elecsys® GAAD Implementation and Validation to Improve Surveillance and Early Detection of HCC |
| NCT ID | NCT05971108 |
| Phase | Phase 4 |
| Status | completed |
| Conditions | Liver Cirrhosis; Hepatocellular Carcinoma |
| Intervention types | diagnostic test |
| Target enrollment | 657 |
| Site countries | United Kingdom |
| Posted | 2023-08-02 |
| Planned start | 2024-01-08 |
| Event | Completed |
| Event date | 2026-09-23 |
| Last update posted | 2026-10-09 |
| enrollment percentile | 92th of 8,879 (median 80, 8.2x median) |
| Peer records CSV (500 records) | 🔒 Click to unlock → |
| CRM-ready export with official source URLs | 🔒 Click to unlock → |
Watch Manchester University NHS Foundation Trust
Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.
Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.
Unlock Manchester University NHS Foundation Trust + 500 peer records (CSV)
Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Sponsor · Phase · Conditions · Enrollment · Countries · Event · Posted · official source URL
- Source agency: ClinicalTrials.gov (U.S. National Library of Medicine) API v2
- Record date: 2026-10-09
- Data refreshed: 2026-11-04
- Refunds on request within 14 days
Top ClinicalTrialStartPulse records (NONUS first): University of Oxford · DejthidaNathaphong · Eye & ENT Hospital of Fudan University · Shanghai First Maternal and Infant Health Hospital affiliate · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Browse all by state and category →
LIVE PUBLIC DATA Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 · Last refreshed: Wed, 04 Nov 2026 06:04:38 GMT
Is this your business? Add a "Listed on Zalwin" badge to your site
Paste this snippet into your website. It links to this public record; nothing is tracked on your site.
Peer benchmark and outreach value: Manchester University NHS Foundation Trust and 6,603 NONUS peers
- NONUS ClinicalTrialStartPulse records like this one: 6,603
- Manchester University NHS Foundation Trust's enrollment: 92nd percentile of 8,879 records
- Timing: Medium: dated in the last 30 days
- Estimated pipeline if you contact every NONUS peer: $1,320,600 (peers × rate × deal size; an estimate from your assumptions, not a forecast)
40 / 100 Score
- Completed: closeout, analysis and the next study ahead.
- 657 participants planned.
What is the ClinicalTrialStartPulse record for Manchester University NHS Foundation Trust?
Manchester University NHS Foundation Trust's Phase 4 study (NCT05971108) in Liver Cirrhosis, first posted 2023-08-02: completed (2026-09-23), in an update posted 2026-10-09.
How does Manchester University NHS Foundation Trust compare to other ClinicalTrialStartPulse records?
This is a top-decile record: its enrollment of 657 is 8.2x the median of 80 across 8,879 records. It is 27 days old, still within a typical 45-day follow-up window.
Manchester University NHS Foundation Trust vs. top 3 peers
| Organization | Location | Amount | Percentile | Record date |
|---|---|---|---|---|
| Manchester University NHS Foundation Trust | NONUS | 657 | 92nd | 2026-10-09 |
| AstraZeneca | NONUS | 731 | 92nd | 2026-10-30 |
| GlaxoSmithKline | NONUS | 303 | 83rd | 2026-11-02 |
| Viatris Inc. | NONUS | 100 | 60th | 2026-11-03 |
Related records
ClinicalTrialStartPulse: Phase 4 ClinicalTrialStartPulse: Outside the US only
How to monitor Manchester University NHS Foundation Trust and peer phase 4 records
Get new ClinicalTrialStartPulse records like Manchester University NHS Foundation Trust by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
Get new studies in your therapeutic areas
ClinicalTrialStartPulse emails new studies and status changes matching your events, phases, sponsor types and site regions.
✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.